Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiansheng Wang

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
ACS Omega|May 25, 2026
Recent Advances in Catalysts for Hydrogen Production: From Fossil-Derived Processes to Sustainable Water Electrolysis and PhotocatalysisGuilherme Mateus Bousada, Noemí Silva de Souza, Géssica Dias, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-onesTiansheng Wang, Leonard Duncan, Wenxin Gu, et al.
Statistics in Medicine|December 30, 2020
Using propensity scores to estimate effects of treatment initiation decisions: State of the scienceMichael Webster-Clark, Til Stürmer, Tiansheng Wang, et al.
Bioorganic Chemistry|June 20, 2021
Potential antibacterial ethanol-bridged purine azole hybrids as dual-targeting inhibitors of MRSAYuanyuan Hu, Shunyou Hu, Guangxing Pan, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitorsTiansheng Wang, Mark W Ledeboer, John P Duffy, et al.
Drugs - Real World Outcomes|April 7, 2022
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)Ying Zhao, Jingru Zhang, Kai Zheng, et al.
Biochemical Genetics|October 2, 2024
A Novel Mitochondrial-Related Gene Signature for the Prediction of Prognosis and Therapeutic Efficacy in Lower-Grade GliomaJingyi Yang, Lei Shen, Jiabin Zhou, et al.
BMJ Open Diabetes Research & Care|October 7, 2025
Investigating the association between incretin-based therapies and thyroid cancer incidence among US Medicare beneficiaries with diabetesClement O Acheampong, John B Buse, Klara R Klein, et al.
Frontiers in Oncology|March 3, 2020
Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell CarcinomaZhexuan Li, Xun Chen, Ming Wei, et al.
Annals of the American Thoracic Society|July 16, 2024
Glucagon-like Peptide 1 Receptor Agonists and Asthma Exacerbations: Which Patients Benefit Most?Tiansheng Wang, Alexander P Keil, John B Buse, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
ACS Omega|May 25, 2026
Recent Advances in Catalysts for Hydrogen Production: From Fossil-Derived Processes to Sustainable Water Electrolysis and PhotocatalysisGuilherme Mateus Bousada, Noemí Silva de Souza, Géssica Dias, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2012
Design, synthesis and biological evaluation of potent NAD+-dependent DNA ligase inhibitors as potential antibacterial agents. Part 2: 4-amino-pyrido[2,3-d]pyrimidin-5(8H)-onesTiansheng Wang, Leonard Duncan, Wenxin Gu, et al.
Statistics in Medicine|December 30, 2020
Using propensity scores to estimate effects of treatment initiation decisions: State of the scienceMichael Webster-Clark, Til Stürmer, Tiansheng Wang, et al.
Bioorganic Chemistry|June 20, 2021
Potential antibacterial ethanol-bridged purine azole hybrids as dual-targeting inhibitors of MRSAYuanyuan Hu, Shunyou Hu, Guangxing Pan, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
A novel chemotype of kinase inhibitors: Discovery of 3,4-ring fused 7-azaindoles and deazapurines as potent JAK2 inhibitorsTiansheng Wang, Mark W Ledeboer, John P Duffy, et al.
Drugs - Real World Outcomes|April 7, 2022
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)Ying Zhao, Jingru Zhang, Kai Zheng, et al.
Biochemical Genetics|October 2, 2024
A Novel Mitochondrial-Related Gene Signature for the Prediction of Prognosis and Therapeutic Efficacy in Lower-Grade GliomaJingyi Yang, Lei Shen, Jiabin Zhou, et al.
BMJ Open Diabetes Research & Care|October 7, 2025
Investigating the association between incretin-based therapies and thyroid cancer incidence among US Medicare beneficiaries with diabetesClement O Acheampong, John B Buse, Klara R Klein, et al.
Frontiers in Oncology|March 3, 2020
Systemic Analysis of RNA Alternative Splicing Signals Related to the Prognosis for Head and Neck Squamous Cell CarcinomaZhexuan Li, Xun Chen, Ming Wei, et al.
Annals of the American Thoracic Society|July 16, 2024
Glucagon-like Peptide 1 Receptor Agonists and Asthma Exacerbations: Which Patients Benefit Most?Tiansheng Wang, Alexander P Keil, John B Buse, et al.
Pageof 18